Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Oxford Academic Health Partners (OAHP) is delighted to have been designated as an NIHR/NHSE/I Academic Health Science Centre following the recent competitive designation process. The designation comes into effect from 1 April 2020 and is for an initial period of five years.

The OAHP includes Oxford Health NHS FT, Oxford University Hospitals NHS FT, Oxford Brookes University and the University of Oxford, who have been working closely together for the last six years in key areas including clinical research, multi-disciplinary education and healthcare innovations supporting the local needs and identified priorities.

OAHP’s vision is to respond to major challenges facing healthcare such as healthy ageing, multimorbidity and mental health, antimicrobial resistance and the best use of digital tools to improve care and patient self-management.

The OAHP is currently focusing their staff, facilities and expertise to overcome the COVID-19 pandemic, and using the close collaborations between the partners to make rapid progress in areas such as clinical trials of new treatments for COVID-19 patients in the NHS.  Daily examples of the excellent work and progress in this area can be seen across the media, with partners joining colleagues across the UK and beyond.

Professor Sir John Bell, Chairman of the OAHP said: “the strength of the partners and our plans are clear in all aspects of our work and our commitment to improve every aspect of patient care, research, innovation, education and training in ways that will benefit the changing NHS and its patients as a whole.”

Professor Keith Channon, Director of the OAHP, said: “This success reflects very strong working relationships between the Partners and the intention is now to deliver even more for current challenges, ongoing patient care, and in teaching, education and training and research and innovation.”

“Each partner has its own special set of skills and areas of expertise and together the OAHP can bring these together and work not only across Oxfordshire but regionally and nationally.”

Read more on the Oxford Academic Health Partners website

Similar stories

Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology

Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.

New study shows higher rate of fractures in people with intellectual disability

In the most comprehensive study of its kind, researchers at the University of Oxford and Oxford Health NHS Foundation Trust found a substantially higher rate of fractures in people with intellectual disability compared with people of the same age and gender without an intellectual disability.

New evidence for how our brains handle surprise

A new study from the Bruno Group is challenging our perceptions of how the different regions of the cerebral cortex function. A group of ‘quiet’ cells in the somatosensory cortex that rarely respond to touch have been found to react mainly to surprising circumstances. The results suggest their function is not necessarily driven by touch, but may indicate an important and previously unidentified role across all the major cortices.

Language learning difficulties in children linked to brain differences

A new study using MRI has revealed structural brain changes in children with developmental language disorder (DLD), a common but under-recognised difficulty in language learning. Children with DLD aged 10-15 showed reduced levels of myelin in areas of the brain associated with speaking and listening to others, and areas involved in learning new skills. This finding is a significant advance in our understanding of DLD and these brain differences may explain the poorer language outcomes in this group.

The Gene Therapists Headline at Glastonbury 2022

Rosie Munday writes about her experience taking science to the masses at the Glastonbury Festival.